Economic evaluation and clinical impact of home medication review (HMR) by community pharmacists among patients with type 2 diabetes mellitus (T2DM)
Not Applicable
Completed
- Conditions
- Metabolic and Endocrine - DiabetesTYPE 2 DIABETES MELLITUS
- Registration Number
- ACTRN12618000839202
- Lead Sponsor
- Faculty of Pharmacy, UiTM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 166
Inclusion Criteria
1.Adult patients (more than 18 years old) diagnosed with Type 2 Diabetes Mellitus.
2.Patients with current HbA1C more than 6.5%
3.Patients taking five (5) or more medications for long term therapy or taking more than twelve (12) doses of medications daily.
4.Patients stayed in 25 km radius from Bandar Pasir Mas Health Clinic
Exclusion Criteria
1.Enduring mental health problems or dependant with caretaker
2.Insufficient understanding of English/ Bahasa Malaysia.
3.Patients who are homeless or do not have a proper place to stay.
4.Foreign workers or non-permanents residents.
5.Patients with blood disorders (i.e. haemolytic anemia, haemoglobinopathy22, chronic lymphocytic leukemia).
6.Patients diagnosed with chronic kidney disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A sample of blood is taken from patients to measure HbA1c (glycated haemoglobin, haemoglobin A1c) value using chromatography based HPLC assay.[0-month, 3-month, and 6-month post-enrolement];Cost-effectiveness of the home medication review program. The cost will be calculated based on the provider (Ministry of Health, Malaysia) perspective.Activity based costing (ABC) will be used in analyzing the true cost for this program. The cost-effectiveness will be assessed by actual cost involve for this program and HbA1c reduction.[0-month, 3-month, 6-month post-enrolment]
- Secondary Outcome Measures
Name Time Method